APA (7th ed.) Citation

Tang, T., Yu, H., Zhang, Y., Li, S., Guo, M., & Saini, E. (2026). Dapagliflozin Augmentation of Sacubitril/Valsartan Therapy in Patients With Heart Failure Following PCI‐Treated Acute Myocardial Infarction: A Meta‐Analysis of Clinical Efficacy and Safety. Cardiology Research & Practice, 2026, 1. https://doi.org/10.1155/crp/1274068

Chicago Style (17th ed.) Citation

Tang, Tang, Huimin Yu, Yun Zhang, Shuang Li, Mu Guo, and Esha Saini. "Dapagliflozin Augmentation of Sacubitril/Valsartan Therapy in Patients With Heart Failure Following PCI‐Treated Acute Myocardial Infarction: A Meta‐Analysis of Clinical Efficacy and Safety." Cardiology Research & Practice 2026 (2026): 1. https://doi.org/10.1155/crp/1274068.

MLA (9th ed.) Citation

Tang, Tang, et al. "Dapagliflozin Augmentation of Sacubitril/Valsartan Therapy in Patients With Heart Failure Following PCI‐Treated Acute Myocardial Infarction: A Meta‐Analysis of Clinical Efficacy and Safety." Cardiology Research & Practice, vol. 2026, 2026, p. 1, https://doi.org/10.1155/crp/1274068.